This inventor holds 1 USPTO granted patent. Top assignee: Amalive Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Aniruddha Potnis and His Patent on Ornithine Phenylacetate
Introduction
Aniruddha Potnis is an inventor associated with King of Prussia, Pennsylvania, United States. His work includes a patent concerning the use of ornithine phenylacetate to treat hyperammonemia.
Latest Patents
Potnis is listed as an inventor on 1 patent: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The patent describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments also address patients with hepatic encephalopathy, a complication of liver disease.
Career Highlights
Potnis is associated with Amalive Limited. The patent reflects work focused on therapeutic dosing and administration for a serious condition linked to chronic liver disease.
Collaborations
The listed coworkers associated with Potnis include Xiaofeng Wang Rears and Jack Tseng. Their names appear alongside his in connection with the patent information provided.
Conclusion
Aniruddha Potnis’s patent work centers on ornithine phenylacetate dosing and its potential use in treating hyperammonemia, including in patients with chronic liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile